Company Profile

Qana Therapeutics Inc. is a clinical / translational biotech firm focused on smart nanoparticle delivery systems that exploit endogenous metabolic pathways (e.g. cholesterol transport) to deliver therapeutic payloads with high specificity. Its lead approach involves creating SCARB1-targeted nanoparticles encapsulating ferroptosis-inducing agents to selectively kill adrenocortical carcinoma (ACC) and other tumors exhibiting relevant surface markers. Qana’s platform aims to overcome limitations of conventional drug delivery (off-target toxicity, low accumulation in tumor tissue) by leveraging tumor metabolic vulnerabilities and selective uptake mechanisms.